AzTrials
AzTrials

Healthy VolunteersNCT07703839

Effects of Breath-Hold vs Standard Interval Training on Fitness in Mountaineers

A study testing Voluntary Hypoventilation Training and Progressive Treadmill Interval Training in people with Healthy Volunteers, run by Mohammadreza Rezaeipour, MD, PhD at 1 site in Iran.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study investigated whether adding structured breath-holds to standard interval training improves cardiorespiratory fitness in recreational mountaineers more than interval training alone. Twenty-four male recreational mountaineers participated in an 8-week progressive treadmill interval training program. Read more about this study

Who is it for?
Ages 25 to 35 years, men onlyHealthy volunteers can take part
Conditions the study is for
Healthy Volunteers
What is being tested?
Voluntary Hypoventilation Training and Progressive Treadmill Interval Training
Could I receive a placebo?
No, everyone receives an active treatment
How many people
24 participants
Where
1 siteIran
Study dates
30 Sep 2023to 30 Nov 2023
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 25 to 35 years
  • Men only
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Male recreational mountaineers aged 25 to 35 years.
  • A minimum of 6 months of mountaineering experience with at least 3 sessions per month.
  • Willingness to attend at least 85% of the scheduled training sessions.
  • Negative responses to all items on the Physical Activity Readiness Questionnaire (PAR-Q).

Who cannot join

  • Diagnosed cardiovascular, respiratory, or musculoskeletal disorders.
  • Current smoking.
  • Use of medications affecting heart rate or blood pressure.
  • Prior experience with structured hypoxic or breath-hold training.

Trial locations and contacts

1 site in 1 country.

Iran1 site
  • Sport Sciences Department, University of Sistan and Baluchestan

    Zahedan, Sistan and Baluchestan, 98135-986

Other trials in Iran

About this study

Official title: Effects of Mild Voluntary Hypoventilation During Progressive Interval Training on Cardiorespiratory Fitness in Recreational Mountaineers: A Clinical Trial

This study investigated whether adding structured breath-holds to standard interval training improves cardiorespiratory fitness in recreational mountaineers more than interval training alone. Twenty-four male recreational mountaineers participated in an 8-week progressive treadmill interval training program. Participants were divided into two groups: a controlled-breathing group that performed structured mid-tidal breath-holds during training, and a free-breathing group that maintained unrestricted breathing. The primary outcomes measured were resting heart rate and estimated maximal oxygen uptake, along with secondary measures including blood pressure and pulmonary function indices. The study aimed to determine if this mild voluntary hypoventilation technique provides additional physiological benefits for altitude preparation.

Read the detailed description

Recreational mountaineers often train at low altitudes without access to specialized hypoxic facilities. While intermittent hypoxic training is an established preparation strategy, the required equipment is costly and inaccessible. Voluntary hypoventilation training (VHT), which involves deliberate breath-holds during exercise, has been proposed as a low-cost alternative. However, its efficacy at producing mild desaturation levels suitable for recreational settings had not been established.

This retrospective clinical trial evaluated the effects of mild VHT on cardiorespiratory fitness. Twenty-four male recreational mountaineers completed a progressive 8-week treadmill interval training program (24 sessions, 65-85% heart rate reserve) between September and November 2023. Participants were allocated to either a controlled-breathing (CB) group or a free-breathing (FB) group. The CB group performed structured mid-tidal breath-holds synchronized to an electronic metronome during approximately 25% of the main training phase, targeting a peripheral oxygen saturation (SpO₂) nadir of 92-94%. The FB group completed the identical exercise protocol with unrestricted breathing, maintaining SpO₂ at or above 97%.

Physiological assessments were conducted at baseline and within 48 hours post-intervention. Measurements included resting cardiovascular parameters (heart rate and blood pressure), estimated maximal oxygen uptake (VO₂max) via a modified Bruce treadmill protocol, and comprehensive pulmonary function testing (spirometry). Continuous SpO₂ monitoring was utilized during all training sessions to ensure protocol adherence and participant safety.

Being tested
Voluntary Hypoventilation Training, Progressive Treadmill Interval Training
Keywords
Voluntary hypoventilation training, Mountaineering, Cardiorespiratory fitness, Interval training, Acclimatization, Aerobic capacity, Pulse oximetry, Breath-Hold Training

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Voluntary Hypoventilation TrainingBehavioural

    Also called VHT; Breath-Hold Training

    A breathing maneuver consisting of structured mid-tidal breath-holds synchronized to an electronic metronome to induce mild voluntary hypoventilation (target SpO₂ nadir 92-94%) during physical exertion.

  • Progressive Treadmill Interval TrainingBehavioural

    Also called Interval Training; Treadmill Exercise

    A cardiovascular exercise protocol involving supervised treadmill sessions with progressive increases in intensity (65-85% heart rate reserve) and duration (30-45 minutes) over an 8-week period.

Study groups in NCT07703839
Study groupRoleWhat they receive
Controlled-Breathing (CB) GroupExperimentalParticipants completed 24 supervised treadmill interval sessions over 8 weeks (65-85% heart rate reserve). During approximately 25% of the main training phase, participants performed structured mid-tidal breath-holds synchronized to an electronic metronome (progressing from 3-count to 6-count cycles), targeting a peripheral oxygen saturation (SpO₂) nadir of 92-94%.
Receives: Behavioral: Voluntary Hypoventilation Training; Behavioral: Progressive Treadmill Interval Training
Free-Breathing (FB) GroupActive comparatorParticipants completed the identical 24 supervised treadmill interval sessions over 8 weeks (65-85% heart rate reserve) with unrestricted breathing throughout all sessions. Continuous SpO₂ monitoring confirmed values remained at or above 97%.
Receives: Behavioral: Progressive Treadmill Interval Training

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Resting Heart Rate

    Resting heart rate (beats per minute) recorded using a 12-lead electrocardiograph after 10 minutes of seated rest in a quiet, temperature-controlled room. The mean value from the final 2 minutes is used for analysis.

    Measured: Baseline (within 48 hours before the first training session) and post-intervention (within 48 hours after the final 8-week training session).

  2. Estimated Maximal Oxygen Uptake (VO2max)

    Estimated VO2max (mL·kg-¹·min-¹) determined using a modified Bruce treadmill protocol until volitional exhaustion. It is calculated from total treadmill time (in minutes) using the Foster equation.

    Measured: Baseline (within 48 hours before the first training session) and post-intervention (within 48 hours after the final 8-week training session).

Secondary outcomes (9)
  1. Systolic Blood Pressure

    Systolic blood pressure (mmHg) measured in triplicate using an automated oscillometric monitor; the average of 3 measurements is retained.

    Measured: Baseline and post-intervention (within 48 hours after the final 8-week training session).

  2. Diastolic Blood Pressure

    Diastolic blood pressure (mmHg) measured in triplicate using an automated oscillometric monitor; the average of 3 measurements is retained.

    Measured: Baseline and post-intervention (within 48 hours after the final 8-week training session).

  3. Tidal Volume (TV)

    Tidal volume (L) measured via calibrated spirometry; the highest value from three technically acceptable maneuvers is retained.

    Measured: Baseline and post-intervention (within 48 hours after the final 8-week training session).

  4. Vital Capacity (VC)

    Vital capacity (L) measured via calibrated spirometry; the highest value from three technically acceptable maneuvers is retained.

    Measured: Baseline and post-intervention (within 48 hours after the final 8-week training session).

  5. Forced Vital Capacity (FVC)

    Vital capacity (L) measured via calibrated spirometry; the highest value from three technically acceptable maneuvers is retained.

    Measured: Baseline and post-intervention (within 48 hours after the final 8-week training session).

  6. Forced Expiratory Volume in 1 Second (FEV1)

    Forced expiratory volume in 1 second (L) measured via calibrated spirometry; the highest value from three technically acceptable maneuvers is retained.

    Measured: Baseline and post-intervention (within 48 hours after the final 8-week training session).

  7. Peak Expiratory Flow (PEF)

    Peak expiratory flow (L/s) measured via calibrated spirometry; the highest value from three technically acceptable maneuvers is retained.

    Measured: Baseline and post-intervention (within 48 hours after the final 8-week training session).

  8. Forced Expiratory Flow at 25-75% of FVC (FEF25-75%)

    Forced expiratory flow at 25-75% of FVC (L/s) measured via calibrated spirometry; the highest value from three technically acceptable maneuvers is retained.

    Measured: Baseline and post-intervention (within 48 hours after the final 8-week training session).

  9. Maximum Voluntary Ventilation (MVV)

    Maximum voluntary ventilation (L/min) measured via calibrated spirometry; the highest value from three technically acceptable maneuvers is retained.

    Measured: Baseline and post-intervention (within 48 hours after the final 8-week training session).

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted14 Jul 2026
  2. Study start30 Sep 2023
  3. Primary completion30 Nov 2023
  4. Study completion30 Nov 2023

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Other
Allocation
Non-randomised
Intervention model
Parallel groups
Model description
A two-arm parallel-group design comparing a controlled-breathing interval training group to a free-breathing interval training group.
Masking
Single blind
Who is masked
Outcomes assessor
Enrolment
24 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07703839
Sponsor's protocol ID
IR.USB.REC.1402.013
Status last verified
Jul 2026
First submitted
9 Jul 2026
Last updated
20 Jul 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: The de-identified dataset and full study protocol are available from the corresponding author upon reasonable request.

Questions about this trial

What is this clinical trial studying?

A study testing Voluntary Hypoventilation Training and Progressive Treadmill Interval Training in people with Healthy Volunteers, run by Mohammadreza Rezaeipour, MD, PhD at 1 site in Iran.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 4 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 20 Jul 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Iran. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Resting Heart Rate (time frame: Baseline (within 48 hours before the first training session) and post-intervention (within 48 hours after the final 8-week training session).). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 20 Jul 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in